Physician

Lena Dumasia, MD

According to 2025 Medicare claims, Lena Dumasia, MD (NPI: 1821015793) practices hematology in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is LANCASTER CANCER CENTER LTD (NPI: 1891889721; TIN: 232174179) and primary practice location at 17602-4013.

Dumasia's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 363 traditional Medicare patients, billed 160,356 HCPCS/CPT codes, and received $2,850,863 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,146 prescription claims across 167 beneficiaries totaling $3,479,407 in drug costs, led by Imbruvica (Ibrutinib). DME data shows 69 claims. Open Payments data shows 105 records totaling $2,247. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $766,384 to $2,850,863. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,484,430 to $3,479,407. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,891 and ending at $3,617.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.4M$2.9M2015 Medicare payment: $766,384 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,158,186 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,522,189 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,590,017 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,698,720 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,876,767 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $1,601,087 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,286,218 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,343,886 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,850,863 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201532560,919$766,384
201640384,146$1,158,186
2017395119,490$1,522,189
201839599,982$1,590,017
2019407102,580$1,698,720
2020365117,079$1,876,767
202135079,900$1,601,087
2022362128,050$2,286,218
2023369124,747$2,343,886
2024363160,356$2,850,863

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.7M$3.5M2015 Drug cost: $1,484,430 (USD; Tot_Drug_Cst)2016 Drug cost: $1,563,629 (USD; Tot_Drug_Cst)2017 Drug cost: $1,371,632 (USD; Tot_Drug_Cst)2018 Drug cost: $1,724,515 (USD; Tot_Drug_Cst)2019 Drug cost: $2,215,617 (USD; Tot_Drug_Cst)2020 Drug cost: $3,242,343 (USD; Tot_Drug_Cst)2021 Drug cost: $2,924,616 (USD; Tot_Drug_Cst)2022 Drug cost: $2,954,905 (USD; Tot_Drug_Cst)2023 Drug cost: $3,490,047 (USD; Tot_Drug_Cst)2024 Drug cost: $3,479,407 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151471,127$1,484,430
20161801,350$1,563,629
20171911,548$1,371,632
20181861,490$1,724,515
20191931,318$2,215,617
20201741,441$3,242,343
20211801,438$2,924,616
20221811,295$2,954,905
20231981,259$3,490,047
20241671,146$3,479,407

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$4.1K$8.1K2015 Medicare payment: $4,779 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $6,325 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $5,833 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $2,551 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $2,461 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $6,111 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $8,100 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $3,966 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $3,158 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $3,088 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151147$4,779
2016N/R58$6,325
201714117$5,833
20181757$2,551
20191775$2,461
202012132$6,111
20213084$8,100
20221487$3,966
20231468$3,158
20241369$3,088

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more262592$95
80053Blood test, comprehensive group of blood chemicals231671$10
85025Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count244860$8
82977Glutamyltransferase (liver enzyme) level231666$7
36415Insertion of needle into vein for collection of blood sample247924$7

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
ImbruvicaIbrutinib711,883$1,029,454
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov501072,478$543,881
RevlimidLenalidomide26728$448,119
BrukinsaZanubrutinib19546$231,217
VerzenioAbemaciclib16448$202,154

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
L8000Breast prosthesis, mastectomy bra, without integrated breast prosthesis form, any size, any typeN1317$1,197
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateYN/R12$786
J8530Cyclophosphamide; oral, 25 mgNN/R12$649
Q0511Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day periodNN/R16$282
E0431Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubingYN/R12$173

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.105$2,247Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Lena Dumasia, MD?

Tedicare shows public-source Medicare data for Lena Dumasia, MD (NPI 1821015793), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lena Dumasia, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lena Dumasia, MD?

Lena Dumasia, MD is linked to LANCASTER CANCER CENTER LTD (billing NPI 1891889721) in the available physician profile data.

Does Lena Dumasia, MD have Open Payments data?

Lena Dumasia, MD has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.